BAJAJ HEALTHCARE
|
|
BOM : 539872     NSE : BAJAJHCARE     | |
LT :  
    Long Term Analysis
Fundamentals : Average
Valuation : Bad [Stock is Expensive] Debt : High |
Updated: |
ST :  
    Short Term Analysis
Quarterly Earnings Trend : Upward
Price Momentum : Upward Pledged Shares : None or < 25% |
Dec 20,2024 |
Price(EOD): ₹ 533.95
This is the End-of-Day (EOD) Stock Price updated daily by 7 pm IST.
|
Pharmaceuticals & Drugs |
MCap: ₹ 1,687.28 Cr |
Industry Peers & Returns | 1W | 1M | 1Y |
BAJAJ HEALTHCARE | 11.6% | 38.6% | 50.1% |
SUN PHARMACEUTICAL INDUSTRIES | -0.1% | 1.7% | 45.7% |
CIPLA | 1.7% | 0.5% | 23.7% |
DR REDDYS LABORATORIES | 5.7% | 12.4% | 18.5% |
ZYDUS LIFESCIENCES | -1.4% | 3.1% | 44.8% |
DIVIS LABORATORIES | -0.1% | -2.2% | 56.9% |
MANKIND PHARMA | 4.2% | 9.8% | 49.8% |
TORRENT PHARMACEUTICALS | 2.2% | 10.6% | 61.7% |
LUPIN | 4.1% | 5.1% | 71.7% |
FUNDAMENTAL ANALYSIS OF BAJAJ HEALTHCARE
 Y : Last Audited Annual/Yearly Data
TTM i.e. Trailing Twelve Months is calculated using last 4 quarterly data and is a good substitute to track last 4 Qtr Annual result before the subsequent year data is published and audited.
Learn More
VALUATION OF BAJAJ HEALTHCARE
 Ratio | Standalone | |
---|---|---|
P/E P/B P/S |
-166.84
P/E Calculated based on Trailing Twelve Months (TTM) Earnings of Rs -10.11 Cr
[Latest Qtr - Sep2024 - Standalone Results ] 6.06
P/B Calculated based on Book Value of Rs 278.36 Cr
[Latest Year - Mar2024 - Standalone Results ] 3.32
P/S Calculated based on Trailing Twelve Months (TTM) Revenues of Rs 0.00 Cr
[Latest Qtr - Sep2024 - Standalone Results ] |
|
Financial Ratios → |
Model | Discount(-)/ Premium(+) |
---|---|
EV/EBIDTA EV/Sales Price/Sales |
234% 697% 249% |
SHARE PRICE MOMENTUM OF BAJAJ HEALTHCARE
BAJAJ HEALTHCARE vs SENSEX
DEBT OF BAJAJ HEALTHCARE
Year | Debt/Equity ratio | |
---|---|---|
Standalone | Consolidated | |
2024 2023 2022 Avg_3yrs |
1.19 1.13 0.78 1.03 |
- - - - |
[Last Annual Data : Mar2024]
|
||
Financial Ratios → |
PLEDGED PROMOTER SHARES OF BAJAJ HEALTHCARE
Pledged Promoter Shares |
0 % | |
---|---|---|
As on : Dec2023 | ||
If less than 25% | Good |
|
If between 25% and 50% | Neutral | |
If greater than 50% | Bad | |
Shareholding Pattern → |
QTRLY RESULTS OF BAJAJ HEALTHCARE
Standalone | Q-o-Q | Y-o-Y |
---|---|---|
Revenue Op Profit Profit Before Tax Profit After Tax |
0.64% 0.08% 22.23% 3.95% |
31.5% 29.4% 137.38% 62.82% |
QtrlyTrend |
8 | |
Latest Qtr: Sep2024 | ||
Quarterly Result Analysis → |
BAJAJ HEALTHCARE related INDICES
You may also like the below Video Courses
FAQ about BAJAJ HEALTHCARE
Is BAJAJ HEALTHCARE good for long term investment?
As on Dec 20,2024, the Fundamentals of BAJAJ HEALTHCARE look Average and hence you may wait for the results to improve to invest for long term ! See Financial Performance of BAJAJ HEALTHCARE . Please look at the other parameters such as Valuation, Price Momentum, News & Corporate Governance and/or consult an Investment Advisor before taking an investment decision!Is BAJAJ HEALTHCARE UnderValued or OverValued?
As on Dec 20,2024, BAJAJ HEALTHCARE is Over Valued based on the estimates of intrinsic value and hence may not be a good buying opportunity according to Share Valuation at this time!What is the Intrinsic Value of BAJAJ HEALTHCARE ?
As on Dec 20,2024, the Intrinsic Value of BAJAJ HEALTHCARE is Rs. 153.05 estimated based on Median of the 3 historical models.Fair Value [Median EV / EBIDTA Model] : Rs. 159.95
Fair Value [Median EV / Sales Model] : Rs. 67.02
Fair Value [Median Price / Sales Model] : Rs. 153.05
Estimated Median Fair Value of BAJAJ HEALTHCARE : Rs. 153.05
The fair value of any stock is always subjective and should, in no way, be taken as a recommendation to buy/sell the same.